Our experience in biologics and biosimilars can help you navigate your brand through this changing landscape.
The biologics market is evolving at a rapid pace. Once considered blockbuster therapies, loss of patent exclusivity has opened up biologics to new competition from cheaper biosimilar versions.
Biosimilars have, in turn, gained increased market acceptance, but breaking into established areas does not come without its challenges. To round off, the latest generation of bio-betters currently in development are set to change the future landscape for both originator biologics and biosimilars even further.
Our team of researchers has a wealth of experience in helping marketers to develop highly competitive brand strategies, whatever the challenge they face.
